The role of high-dose methotrexate with citrovorum factor “rescue” in the treatment of osteogenic sarcoma
- 30 April 1977
- journal article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 2 (3-4), 261-266
- https://doi.org/10.1016/0360-3016(77)90083-9
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Weekly high-dose methotrexate-citrovorum factor in osteogenic sarcoma.Pre-surgical treatment of primary tumor and of overt pulmonary metastasesCancer, 1977
- Multidisciplinary treatment for macrometastatic osteogenic sarcoma.BMJ, 1976
- Chemotherapy,en bloc resection, and prosthetic bone replacement in the treatment of osteogenic sarcomaCancer, 1976
- New Approaches to Cancer Chemotherapy with MethotrexateNew England Journal of Medicine, 1975
- Combination chemotherapy and radiation therapy in the treatment of metastatic osteogenic sarcomaCancer, 1975
- Adjuvant Methotrexate and Citrovorum-Factor Treatment of Osteogenic SarcomaNew England Journal of Medicine, 1974
- High-dose methotrexate with citrovorum factor rescue and adriamycin in childhood osteogenic sarcomaCancer, 1974
- Favorable response of metastatic osteogenic sarcoma to pulse high-dose methotrexate with citrovorum rescue and radiation therapyCancer, 1973
- Doxorubicin in DisseminatedPublished by American Medical Association (AMA) ,1972
- The therapy of osteogenic sarcoma: Current status and thoughts for the futureJournal of Surgical Oncology, 1972